ArticleMolecular biotechnology2025

Development of a Novel Risk Signature for Predicting the Prognosis and Immunotherapeutic Response of Prostate Cancer by Integrating Ferroptosis and Immune-Related Genes.

Yang Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.